Warning: The NCBI web site requires JavaScript to function. more...
Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials.
Couri CE, Voltarelli JC.
Diabetol Metab Syndr. 2009 Oct 16;1(1):19.
Related citations
Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
[No authors listed]
Ann Intern Med. 1998 Apr 1;128(7):517-23.
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ.
Arch Intern Med. 2009 Jul 27;169(14):1307-16.
Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
Steffes MW, Sibley S, Jackson M, Thomas W.
Diabetes Care. 2003 Mar;26(3):832-6.
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.
Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934.
Potential role of stem cell therapy in type 1 diabetes mellitus.
Arq Bras Endocrinol Metabol. 2008 Mar;52(2):407-15. Review.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP.
Pharmacoeconomics. 2004;22(6):389-411. Review.
Autologous stem cell transplantation for early type 1 diabetes mellitus.
Autoimmunity. 2008 Dec;41(8):666-72.
Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ, Bailey CJ.
Drugs. 2005;65(3):385-411. Review.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376.
Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes.
Curr Stem Cell Res Ther. 2011 Mar;6(1):10-5. Review.
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Diabetes Care. 1999 Jan;22(1):99-111.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC.
JAMA. 2009 Apr 15;301(15):1573-9.
Implementation of treatment protocols in the Diabetes Control and Complications Trial.
Diabetes Care. 1995 Mar;18(3):361-76.
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes. 1996 Oct;45(10):1289-98.
Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.
Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
J Clin Endocrinol Metab. 1987 Jul;65(1):30-6.
Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; DCCT/EDIC Research Group.
Circulation. 2009 Jun 9;119(22):2886-93. Epub 2009 May 26.
Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
Genuth S.
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):104-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on